应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02268 药明合联
未开盘 04-23 16:08:51
36.700
+1.900
+5.46%
最高
37.100
最低
35.150
成交量
748.69万
今开
36.150
昨收
34.800
日振幅
5.60%
总市值
441.13亿
流通市值
441.13亿
总股本
12.02亿
成交额
2.72亿
换手率
0.62%
流通股本
12.02亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
恒生指数收涨0.78% 南向资金净买入额超210亿港元
美港电讯 · 04-22 08:18
恒生指数收涨0.78% 南向资金净买入额超210亿港元
药明合联04月22日获主力加仓972万元
市场透视 · 04-22 08:15
药明合联04月22日获主力加仓972万元
药明合联盘中异动 急速上涨5.18%
市场透视 · 04-22 01:44
药明合联盘中异动 急速上涨5.18%
药明合联04月17日主力净流入878万元 散户资金抛售
市场透视 · 04-17
药明合联04月17日主力净流入878万元 散户资金抛售
药明合联04月15日遭主力抛售577万元
市场透视 · 04-15
药明合联04月15日遭主力抛售577万元
药明合联盘中异动 股价大跌5.09%
市场透视 · 04-15
药明合联盘中异动 股价大跌5.09%
药明合联根据2024年股份计划授出538.77万股受限制股份
智通财经 · 04-15
药明合联根据2024年股份计划授出538.77万股受限制股份
【港股医药股多数走强 再鼎医药涨超13%】截至发稿,再鼎医药(09688.HK)涨13.51%、来凯医药-B(02105.HK)涨10.34%、基石药业-B(02616.HK)涨6.28%、腾盛博药-B(02137.HK)涨6.17%、药明合联(02268.HK)涨5.94%。
金融界 · 04-14
【港股医药股多数走强 再鼎医药涨超13%】截至发稿,再鼎医药(09688.HK)涨13.51%、来凯医药-B(02105.HK)涨10.34%、基石药业-B(02616.HK)涨6.28%、腾盛博药-B(02137.HK)涨6.17%、药明合联(02268.HK)涨5.94%。
药明合联03月11日主力净流入17万元 散户资金抛售
市场透视 · 03-11
药明合联03月11日主力净流入17万元 散户资金抛售
大摩:药明系估值具上行空间 看好药明合联较不受地缘政治影响
格隆汇 · 03-11
大摩:药明系估值具上行空间 看好药明合联较不受地缘政治影响
药明合联03月10日遭主力抛售78万元
市场透视 · 03-10
药明合联03月10日遭主力抛售78万元
港股异动 | 药明合联(02268)涨超5% 全年纯利同比预增超2.6倍 里昂看好公司市场份额增长潜力
智通财经 · 03-07
港股异动 | 药明合联(02268)涨超5% 全年纯利同比预增超2.6倍 里昂看好公司市场份额增长潜力
药明合联盘中异动 股价大涨5.17%报36.600港元
市场透视 · 03-07
药明合联盘中异动 股价大涨5.17%报36.600港元
药明合联03月06日获主力加仓6万元
市场透视 · 03-06
药明合联03月06日获主力加仓6万元
药明合联盘中异动 早盘股价大涨5.04%
市场透视 · 03-06
药明合联盘中异动 早盘股价大涨5.04%
药明合联盘中异动 下午盘急速上涨5.02%
市场透视 · 03-05
药明合联盘中异动 下午盘急速上涨5.02%
药明合联03月04日遭主力抛售99万元
市场透视 · 03-04
药明合联03月04日遭主力抛售99万元
里昂:首予药明合联“跑赢大市”评级 目标价44.3港元
新浪港股 · 02-28
里昂:首予药明合联“跑赢大市”评级 目标价44.3港元
里昂:首予药明合联(02268)“跑赢大市”评级 目标价44.3港元
智通财经 · 02-28
里昂:首予药明合联(02268)“跑赢大市”评级 目标价44.3港元
药明合联盘中异动 大幅下挫5.12%报32.450港元
市场透视 · 02-28
药明合联盘中异动 大幅下挫5.12%报32.450港元
加载更多
公司概况
公司名称:
药明合联
所属市场:
SEHK
上市日期:
--
主营业务:
药明合联生物技术有限公司是一家主要从事提供提供抗体偶联药物(ADC)及其他生物偶联药物的全面合同研究、开发及制造组织(CRDMO)服务的投资控股公司。该公司的服务包括生物偶联药物、单克隆抗体中间体及生物偶联药物相关连接子及有效载荷的发现、工艺开发及优良生产质量管理规范(GMP)生产。该公司透过按有偿服务(FFS)基准的合约和按全时当量(FTE)基准的合约向客户提供CRDMO服务。该公司主要在国内市场、北美、欧洲和世界其他地区市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02268","market":"HK","secType":"STK","nameCN":"药明合联","latestPrice":36.7,"timestamp":1745395731016,"preClose":34.8,"halted":0,"volume":7486937,"delay":0,"floatShares":1202000000,"shares":1202000000,"eps":0.9507419947385983,"marketStatus":"未开盘","change":1.9,"latestTime":"04-23 16:08:51","open":36.15,"high":37.1,"low":35.15,"amount":271704554,"amplitude":0.056034,"askPrice":36.75,"askSize":1500,"bidPrice":36.7,"bidSize":16500,"shortable":3,"etf":0,"ttmEps":0.8841544332275363,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1745458200000},"marketStatusCode":0,"adr":0,"listingDate":1700150400000,"exchange":"SEHK","adjPreClose":34.8,"openAndCloseTimeList":[[1745371800000,1745380800000],[1745384400000,1745395200000]],"volumeRatio":0.732644,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02268","defaultTab":"news","newsList":[{"id":"2529376344","title":"恒生指数收涨0.78% 南向资金净买入额超210亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529376344","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529376344?lang=zh_cn&edition=full","pubTime":"2025-04-22 16:18","pubTimestamp":1745309914,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU0577902298.EUR","LU0469268626.HKD","MPNGY","02833","LU0823039010.USD","02291","LU0011963245.USD","YANG","MHImain","HHImain","BK4503","SG9999002562.SGD","03690","LU0501845795.SGD","LU2242644610.SGD","HSTECH","LU0143863198.USD","MCHmain","HSI","HSCEI","600547","BK0242","HSImain","02268","89618","LU0140636845.USD","07226","01477","LU0683595622.HKD","09939","LU1328615791.USD","LU1719994722.HKD","06693","01787","600988","LU1224444064.USD","LU1008478684.HKD","01818","513600","159938","JD","HMTD.SI","01182","BK4505","LU0181495838.USD","01672","LU0455707207.USD","09618","159562","BK1198"],"gpt_icon":0},{"id":"2529321257","title":"药明合联04月22日获主力加仓972万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529321257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529321257?lang=zh_cn&edition=full","pubTime":"2025-04-22 16:15","pubTimestamp":1745309749,"startTime":"0","endTime":"0","summary":"04月22日, 药明合联股价涨9.26%,报收34.80元,成交金额3.21亿元,换手率0.79%,振幅9.26%,量比0.90。药明合联今日主力资金净流入972万元,上一交易日主力净流入878万元。该股近5个交易日上涨4.46%,主力资金累计净流出2392万元;近20日主力资金累计净流出4877万元,其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422170850a4623a10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422170850a4623a10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","SG9999014674.SGD","BK1141","02268"],"gpt_icon":0},{"id":"2529362426","title":"药明合联盘中异动 急速上涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529362426","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529362426?lang=zh_cn&edition=full","pubTime":"2025-04-22 09:44","pubTimestamp":1745286268,"startTime":"0","endTime":"0","summary":"2025年04月22日早盘09时44分,药明合联股票出现波动,股价大幅上涨5.18%。截至发稿,该股报33.500港元/股,成交量131.35万股,换手率0.11%,振幅4.87%。资金方面,该股资金流入2329.89万港元,流出1330.84万港元。药明合联股票所在的生物技术行业中,整体涨幅为0.69%。其相关个股中,歌礼制药-B、诺诚健华、荃信生物-B涨幅较大,振幅较大的相关个股有博安生物、荃信生物-B、科伦博泰生物-B,振幅分别为13.23%、11.22%、10.72%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422094428973ffc02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422094428973ffc02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","SG9999014674.SGD","02268","BK1141"],"gpt_icon":0},{"id":"2528796556","title":"药明合联04月17日主力净流入878万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2528796556","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528796556?lang=zh_cn&edition=full","pubTime":"2025-04-17 16:15","pubTimestamp":1744877713,"startTime":"0","endTime":"0","summary":"04月17日, 药明合联股价涨3.24%,报收31.85元,成交金额2.01亿元,换手率0.53%,振幅5.67%,量比0.46。药明合联今日主力资金净流入878万元,上一交易日主力净流出106万元。该股近5个交易日下跌0.31%,主力资金累计净流出4401万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出5315万元,其中净流出天数为13日。该股主力净额占比0.02%,港股市场排名183/2651。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417165915a45c41b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417165915a45c41b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","LU2488822045.USD","SG9999014674.SGD","02268"],"gpt_icon":0},{"id":"2527461067","title":"药明合联04月15日遭主力抛售577万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527461067","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527461067?lang=zh_cn&edition=full","pubTime":"2025-04-15 16:16","pubTimestamp":1744704997,"startTime":"0","endTime":"0","summary":"04月15日, 药明合联股价跌4.95%,报收33.60元,成交金额3.92亿元,换手率0.97%,振幅7.92%,量比0.56。药明合联今日主力资金净流出577万元,连续4日净流出,上一交易日主力净流出3561万元。近一年数据显示,该股主力连续4日净流出后,次日下跌概率为25.00%,平均跌幅为3.85%。该股近5个交易日上涨16.12%,主力资金累计净流出5799万元;近20日主力资金累计净流出6236万元,其中净流出天数为13日。该股主力净额占比0.01%,港股市场排名2468/2651。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415171602a6bb04e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415171602a6bb04e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","SG9999014674.SGD","02268","LU2488822045.USD"],"gpt_icon":1},{"id":"2527101832","title":"药明合联盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527101832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527101832?lang=zh_cn&edition=full","pubTime":"2025-04-15 10:11","pubTimestamp":1744683080,"startTime":"0","endTime":"0","summary":"2025年04月15日早盘10时11分,药明合联股票出现异动,股价快速下挫5.09%。截至发稿,该股报33.550港元/股,成交量305.227万股,换手率0.25%,振幅5.80%。资金方面,该股资金流入3871.59万港元,流出4829.26万港元。药明合联股票所在的生物技术行业中,整体涨幅为1.53%。其相关个股中,映恩生物-B、歌礼制药-B、维升药业-B涨幅较大,振幅较大的相关个股有映恩生物-B、科伦博泰生物-B、康诺亚-B,振幅分别为43.34%、13.40%、8.39%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415101120a6bab0a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415101120a6bab0a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","02268","BK1141","LU2488822045.USD"],"gpt_icon":0},{"id":"2527746431","title":"药明合联根据2024年股份计划授出538.77万股受限制股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2527746431","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527746431?lang=zh_cn&edition=full","pubTime":"2025-04-15 08:36","pubTimestamp":1744677411,"startTime":"0","endTime":"0","summary":"智通财经APP讯, 药明合联 (02268)发布公告,于2025年4月14日,根据2024年股份计划,其已批准向287名承授人(其中3名为董事,其余284名承授人为集团雇员)授出538.77万股受限制股份,惟须经选定参与者接纳。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415085101a459142c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415085101a459142c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","BK1141","02268","LU2488822045.USD"],"gpt_icon":0},{"id":"2527945435","title":"【港股医药股多数走强 再鼎医药涨超13%】截至发稿,再鼎医药(09688.HK)涨13.51%、来凯医药-B(02105.HK)涨10.34%、基石药业-B(02616.HK)涨6.28%、腾盛博药-B(02137.HK)涨6.17%、药明合联(02268.HK)涨5.94%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527945435","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527945435?lang=zh_cn&edition=full","pubTime":"2025-04-14 09:42","pubTimestamp":1744594975,"startTime":"0","endTime":"0","summary":"截至发稿,再鼎医药(09688.HK)涨13.51%、来凯医药-B(02105.HK)涨10.34%、基石药业-B(02616.HK)涨6.28%、腾盛博药-B(02137.HK)涨6.17%、药明合联(02268.HK)涨5.94%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/14094249513998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4531","159718","BK4585","02268","BK4548","BK1574","02137","BK1588","ZLAB","02616","BK1141","BK4588","SG9999014674.SGD","09688","02105","LU2488822045.USD","BK4139","BK4526","BK1587","BK1161"],"gpt_icon":0},{"id":"2518718886","title":"药明合联03月11日主力净流入17万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2518718886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518718886?lang=zh_cn&edition=full","pubTime":"2025-03-11 16:16","pubTimestamp":1741680993,"startTime":"0","endTime":"0","summary":"03月11日, 药明合联股价涨2.31%,报收35.45元,成交金额1.27亿元,换手率0.30%,振幅6.93%,量比0.92。药明合联今日主力资金净流入17万元,上一交易日主力净流出78万元。该股近5个交易日上涨11.15%,主力资金累计净流入309万元;近20日主力资金累计净流入3980万元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311170004a1d49e91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311170004a1d49e91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","SG9999014674.SGD","02268","BK1141"],"gpt_icon":0},{"id":"2518759344","title":"大摩:药明系估值具上行空间 看好药明合联较不受地缘政治影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2518759344","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518759344?lang=zh_cn&edition=full","pubTime":"2025-03-11 11:11","pubTimestamp":1741662662,"startTime":"0","endTime":"0","summary":"大摩大致维持药明生物2024年收入预测不变,净利润预测上调3%,目标价维持31.6港元不变。为反映拟出售ATU业务的影响,大摩将药明康德2024至2026年收入预测下调2%至10%,目标价上调至74.3港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031111135298a34ab2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031111135298a34ab2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","SG9999014674.SGD","LU2488822045.USD","02268"],"gpt_icon":0},{"id":"2518021915","title":"药明合联03月10日遭主力抛售78万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518021915","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518021915?lang=zh_cn&edition=full","pubTime":"2025-03-10 16:16","pubTimestamp":1741594566,"startTime":"0","endTime":"0","summary":"03月10日, 药明合联股价跌2.94%,报收34.65元,成交金额1.43亿元,换手率0.34%,振幅6.86%,量比1.05。药明合联今日主力资金净流出78万元,上一交易日主力净流出248万元。该股近5个交易日上涨7.04%,主力资金累计净流入193万元;近20日主力资金累计净流入4537万元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310170100a269ba5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310170100a269ba5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02268","SG9999014674.SGD","LU2488822045.USD"],"gpt_icon":0},{"id":"2517123543","title":"港股异动 | 药明合联(02268)涨超5% 全年纯利同比预增超2.6倍 里昂看好公司市场份额增长潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2517123543","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517123543?lang=zh_cn&edition=full","pubTime":"2025-03-07 11:53","pubTimestamp":1741319593,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,药明合联涨超5%,截至发稿,涨5.75%,报36.8港元,成交额7740.48万港元。消息面上,药明合联此前发盈喜,预期该集团截至2024年12月31日止年度的收入、纯利和经调整纯利将分别同比增长超过85%、260%及170%。里昂研报指出,药明合联2023年的市场份额为14.5%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258946.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SG9999014674.SGD","LU2488822045.USD","BK1141","02268"],"gpt_icon":0},{"id":"2517014241","title":"药明合联盘中异动 股价大涨5.17%报36.600港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517014241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517014241?lang=zh_cn&edition=full","pubTime":"2025-03-07 10:38","pubTimestamp":1741315129,"startTime":"0","endTime":"0","summary":"2025年03月07日早盘10时38分,药明合联股票出现异动,股价急速上涨5.17%。截至发稿,该股报36.600港元/股,成交量119.901万股,换手率0.10%,振幅6.61%。资金方面,该股资金流入2280.01万港元,流出1512.88万港元。药明合联股票所在的生物技术行业中,整体跌幅为0.07%。其相关个股中,帝王国际投资、云顶新耀-B、百奥赛图-B涨幅较大,振幅较大的相关个股有帝王国际投资、创胜集团-B、云顶新耀-B,振幅分别为29.03%、18.09%、13.08%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307103849989f4aad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307103849989f4aad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","LU2488822045.USD","02268","BK1141"],"gpt_icon":0},{"id":"2517136711","title":"药明合联03月06日获主力加仓6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517136711","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517136711?lang=zh_cn&edition=full","pubTime":"2025-03-06 16:17","pubTimestamp":1741249027,"startTime":"0","endTime":"0","summary":"03月06日, 药明合联股价涨3.26%,报收34.80元,成交金额1.59亿元,换手率0.38%,振幅4.90%,量比1.23。药明合联今日主力资金净流入6万元,上一交易日主力净流入611万元。该股近5个交易日上涨1.61%,主力资金累计净流入319万元;近20日主力资金累计净流入3389万元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306170133abeb14ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306170133abeb14ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","BK1141","02268","LU2488822045.USD"],"gpt_icon":0},{"id":"2517526908","title":"药明合联盘中异动 早盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517526908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517526908?lang=zh_cn&edition=full","pubTime":"2025-03-06 10:10","pubTimestamp":1741227021,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘10时10分,药明合联股票出现波动,股价快速上涨5.04%。截至发稿,该股报35.400港元/股,成交量161.755万股,换手率0.13%,振幅4.60%。药明合联股票所在的生物技术行业中,整体涨幅为1.83%。消息层面,截至10时10分,《药明合联与LigaChem Biosciences签署合作备忘录 加速ADC开发》资讯为影响药明合联的重要信息。此外,LigaChem Biosciences还将利用药明合联一体化ADC药物开发与生产平台,为多个ADC项目提供有力支持。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306101022963b8324&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306101022963b8324&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268","SG9999014674.SGD","LU2488822045.USD","BK1141"],"gpt_icon":0},{"id":"2517963150","title":"药明合联盘中异动 下午盘急速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517963150","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517963150?lang=zh_cn&edition=full","pubTime":"2025-03-05 14:28","pubTimestamp":1741156118,"startTime":"0","endTime":"0","summary":"2025年03月05日下午盘14时28分,药明合联股票出现波动,股价大幅拉升5.02%。截至发稿,该股报33.450港元/股,成交量395.128万股,换手率0.33%,振幅4.40%。药明合联股票所在的生物技术行业中,整体涨幅为1.60%。消息层面,截至14时28分,《药明合联与LigaChem Biosciences签署合作备忘录 加速ADC开发》资讯为影响药明合联的重要信息。此外,LigaChem Biosciences还将利用药明合联一体化ADC药物开发与生产平台,为多个ADC项目提供有力支持。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305142838989cb270&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305142838989cb270&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","SG9999014674.SGD","02268","BK1141"],"gpt_icon":0},{"id":"2516625452","title":"药明合联03月04日遭主力抛售99万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516625452","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516625452?lang=zh_cn&edition=full","pubTime":"2025-03-04 17:39","pubTimestamp":1741081187,"startTime":"0","endTime":"0","summary":"03月04日, 药明合联股价跌0.31%,报收31.85元,成交金额5210万元,换手率0.14%,振幅2.97%,量比0.34。药明合联今日主力资金净流出99万元,连续4日净流出,上一交易日主力净流出43万元。近一年数据显示,该股主力连续4日净流出后,次日下跌概率为50.00%,平均跌幅为6.23%。该股近5个交易日下跌5.47%,主力资金累计净流出994万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入3122万元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304174956a25ea7af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304174956a25ea7af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02268","SG9999014674.SGD","LU2488822045.USD"],"gpt_icon":0},{"id":"2514180853","title":"里昂:首予药明合联“跑赢大市”评级 目标价44.3港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514180853","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514180853?lang=zh_cn&edition=full","pubTime":"2025-02-28 15:01","pubTimestamp":1740726060,"startTime":"0","endTime":"0","summary":" 里昂发布研报称,首次覆盖药明合联,给予“跑赢大市”评级,目标价44.3港元。药明合联2023年市场份额为14.5%,预计2024至2026财年收入增长分别为85%、40%及32%,每股盈利预测复合年均增长率为34%,该行的预测较市场共识高39%至43%。据外部机构预测,该公司2022至2030年的全球抗体—药物复合物外包市场收入复合年均增长率预计达到28%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tob/2025-02-28/doc-inemzitr0032822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02268"],"gpt_icon":0},{"id":"2514836009","title":"里昂:首予药明合联(02268)“跑赢大市”评级 目标价44.3港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514836009","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514836009?lang=zh_cn&edition=full","pubTime":"2025-02-28 11:34","pubTimestamp":1740713695,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,里昂发布研报称,首次覆盖药明合联,给予“跑赢大市”评级,目标价44.3港元。药明合联2023年市场份额为14.5%,预计2024至2026财年收入增长分别为85%、40%及32%,每股盈利预测复合年均增长率为34%,该行的预测较市场共识高39%至43%。据外部机构预测,该公司2022至2030年的全球抗体—药物复合物外包市场收入复合年均增长率预计达到28%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1255981.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02268"],"gpt_icon":0},{"id":"2514398870","title":"药明合联盘中异动 大幅下挫5.12%报32.450港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514398870","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514398870?lang=zh_cn&edition=full","pubTime":"2025-02-28 11:22","pubTimestamp":1740712972,"startTime":"0","endTime":"0","summary":"2025年02月28日早盘11时22分,药明合联股票出现异动,股价快速下挫5.12%。截至发稿,该股报32.450港元/股,成交量129.764万股,换手率0.11%,振幅6.73%。资金方面,该股资金流入1216.84万港元,流出2549.94万港元。药明合联股票所在的生物技术行业中,整体涨幅为0.39%。其相关个股中,迈博药业-B、帝王国际投资、奥星生命科技涨幅较大,振幅较大的相关个股有帝王国际投资、科笛-B、昭衍新药,振幅分别为23.08%、16.80%、13.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502281122529895bc87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502281122529895bc87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","SG9999014674.SGD","LU2488822045.USD","02268"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.youyuan.com.hk","stockEarnings":[{"period":"1week","weight":0.1896},{"period":"1month","weight":-0.1283},{"period":"3month","weight":0.2743},{"period":"6month","weight":0.5751},{"period":"1year","weight":0.8976},{"period":"ytd","weight":0.1974}],"compareEarnings":[{"period":"1week","weight":0.0482},{"period":"1month","weight":-0.0767},{"period":"3month","weight":0.1204},{"period":"6month","weight":0.072},{"period":"1year","weight":0.3116},{"period":"ytd","weight":0.1003}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"药明合联生物技术有限公司是一家主要从事提供提供抗体偶联药物(ADC)及其他生物偶联药物的全面合同研究、开发及制造组织(CRDMO)服务的投资控股公司。该公司的服务包括生物偶联药物、单克隆抗体中间体及生物偶联药物相关连接子及有效载荷的发现、工艺开发及优良生产质量管理规范(GMP)生产。该公司透过按有偿服务(FFS)基准的合约和按全时当量(FTE)基准的合约向客户提供CRDMO服务。该公司主要在国内市场、北美、欧洲和世界其他地区市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":0.010265},{"month":2,"riseRate":0.666667,"avgChangeRate":0.058284},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.010372},{"month":4,"riseRate":0.555556,"avgChangeRate":0.03555},{"month":5,"riseRate":0.333333,"avgChangeRate":0.006014},{"month":6,"riseRate":0.4,"avgChangeRate":-0.032735},{"month":7,"riseRate":0.4,"avgChangeRate":0.011785},{"month":8,"riseRate":0.4,"avgChangeRate":-0.114063},{"month":9,"riseRate":0.333333,"avgChangeRate":0.019767},{"month":10,"riseRate":0.777778,"avgChangeRate":0.151657},{"month":11,"riseRate":0.333333,"avgChangeRate":0.008796},{"month":12,"riseRate":0.111111,"avgChangeRate":-0.068876}],"exchange":"SEHK","name":"药明合联","nameEN":"WUXI XDC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明合联(02268)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明合联(02268)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明合联,02268,药明合联股票,药明合联股票老虎,药明合联股票老虎国际,药明合联行情,药明合联股票行情,药明合联股价,药明合联股市,药明合联股票价格,药明合联股票交易,药明合联股票购买,药明合联股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明合联(02268)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明合联(02268)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}